The pathogenicity of neutralization-resistant mutants of the enteric coronavirus transmissible gastroenteritis virus (TGEV) was examined in the newborn piglet. The parental virus (Purdue-ll5 strain), as well as several mutants selected using monoclonal antibodies (MAbs) directed to antigenic sites A and B, caused an acute enteritis with 100 % mortality. By contrast, most of the site D (MAb 40.1) mutants exhibited a strongly reduced enteropathogenicity, leading to the survival of animals inoculated with up to 1000-fold the 100 % lethal dose of parental virus. Such a phenotypical change was correlated with point mutations or a small deletion, all located within the S gene sequence coding for the to Cys-155 segment of the mature polypeptide.
Introduction
Transmissible gastroenteritis virus (TGEV) is an important swine pathogen which causes a fatal diarrhoea in newborn piglets (for review see Pensaert et al., 1993) . The virus replicates in differentiated enterocytes, thus inducing a severe atrophy of the villi (Pensaert et al., 1970) . TGEV belongs to the Coronaviridae, a family of enveloped viruses having a large (around 30 kb), positivesense RNA genome (for review see Spaan et al., 1988; Eleouet et al., 1995) . TGEV virions are comprised of a nucleocapsid protein (N, 47 kDa), two envelope glycoproteins (S, 220 kDa and M, 29-36 kDa) and a minor membrane protein (sM, 10 kDa) Godet et al., 1992) . The virus spikes, formed of S protein trimers, mediate the entry of TGEV into target cells through interaction with aminopeptidase N (APN), an ectoenzyme abundantly expressed on the small intestine enterocytes (Delmas et al., 1990 (Delmas et al., , 1992 . More recently, it has been reported that a 200 kDa protein restricted to the villous enterocytes of the newborn pig may be an additional receptor for TGEV which contributes to the age sensitivity of these animals to the virus (Weingartl & Derbyshire, 1994) . The domain of TGEV S involved in * Author for correspondence. Fax +33 1 34 65 26 21. e-mail laude @ biotec.jouy.inra.fr t Present address: Unit6 de Pathologic lnfectieuse Immunologic, Institut National de la Recherche Agronomique, Nouzilly, France. APN receptor recognition (Godet et al., 1994) , as well as several neutralization-mediating sites (Correa et al., 1990; Delmas et al., 1990) , have been mapped on the primary structure of the polypeptide chain. Although molecular determinant(s) responsible for the enteric tropism of the virus are assumed to be carried by the S protein (Sanchez et al., 1992; Laude et al., 1993) , their identification has not been achieved so far.
Antigenic variants have proven to be valuable tools for studies of the pathogenesis of many viruses (for review see Prabhakar & Notkins, 1984) , including that of a neuropathogenic coronavirus, mouse hepatitis virus (MHV; Fazakerley et al., 1992; Wang et al., 1992) . In the present study, we have examined the pathogenicity for the swine neonate of a series of TGEV neutralization escape mutants. This allowed the identification of several mutations in the S-encoding gene which do not affect the replication of the virus in cell culture but lead to a dramatic attenuation of the enteropathogenicity.
Methods
TGEV viruses. The high passage Purdue-ll5 strain was used as a parental virus for the generation of mutants. Production and titration of the virus stocks in the ST cell line was done as previously reported . The vaccine strain Nouzilly and the field noncultivated strain Gep II (Aynaud et al., 1985) were used for comparison.
Escape mutants. The selection of neutralization escape mutants using the anti-S monoclonal antibodies (MAbs) defining antigenic sites A, B and D has been reported previously (Delmas et al., 1986) . Stocks of mutant viruses were produced under selection with the relevant MAb diluted 1 : 100.
Direct RNA sequencing. Genomic RNA was prepared from virions semipurified by ultracentrifugation through a 25 % glycerol cushion. RNA was extracted with phenol-chloroform after treatment of virions with proteinase K plus SDS. After precipitation with 2 M-LiC1, RNA was suspended in water and heat denatured (100 °C) for 1 min . Reverse transcription was performed as originally described by Zimmern & Kaesberg (1978) . Priming was done with synthetic primers complementary to the TGEV S gene sequence (Rasschaert &Laude, 1987) : 5' GTGCCACGAGTCCTATCATT, ACATCACATGGCGTTACAGA, TAATCTGTGCAGGAATCTAG, AACTTACAATTAGCACCAAC and TTGCAAGTAGAATGAAC-ATA for the 26 kDa protein-encoding region (A and B sites; see text); 51 TTAGTTAGAAGGAACCAATTAATTAA and AACTAATAC-GGTAACTAGCA for the 13 kDa protein-encoding region (D site). The elongation reaction was performed at 42 °C for 20 rain with 1 to 2 ~tg of RNA per sequence, reverse transcriptase (Appligbne), [35S]dATP (Amersham) and a deoxynucleotide: dideoxynucleotide ratio of 3.75:1, 5:1, 6:1 and 12.5:1 for nucleotides T, C, G and A, respectively. The samples were analysed on 6 % acrylamide plus 8 Murea gels.
Animal experiments. The Large White pregnant sows used originated from a breeding unit with no history of TGEV or TGEV-related porcine respiratory coronavirus (PRCV) and were seronegative for anti-TGEV antibodies as judged by fixed cell immunoperoxidase (To & Bernard, 1992) and neutralization tests. The piglets received colostrum and milk up to 3 days after delivery and were then placed in individual cages in protected units (animal facilities from INRA-Nouzilly). Each experiment was carried out with nine to 15 piglets from one or two sows and randomly assigned to groups of three to six animals. They were fed twice a day with a measured quantity of sterilized cow milk and water was left ad libitum. After 2 days of weaning followed by an overnight starving, the piglets were orally infected with virus diluted in 5 ml of Eagle's MEM or mock-infected with 5 ml MEM alone. The designation of the virus samples was cryptic. The piglets were individually weighed each morning and a clinical assessment was made twice a day. The observations were pursued up to 10 days post-infection (p.i.).
Results

Sequence changes in TGEV neutralization escape mutants
The mutants used in these experiments were derived during an earlier study (Delmas et al., 1986) . Their respective characteristics are listed in Table 1 . Seven mutants were selected toward the neutralizing MAb 40.1, which defines antigenic site D together with other MAbs devoid of neutralizing activity. Five mutants were selected toward four different A or B site-specific MAbs, which are all strongly neutralizing. The majority of these mutants were naturally occurring and exhibited a plaque phenotype indistinguishable from that of the parental virus (Purdue-115 strain). As previously reported, no spontaneous mutant could be selected toward the two site A-specific MAbs 51.13 and 12.18; the 12.18 small plaque mutant used was obtained after chemical mutagenesis.
The genetic changes associated with neutralization resistance were determined by partial RNA sequencing of the S gene using oligonucleotide-primed reverse transcriptase. As shown in Table 1 , only single nucleotide changes were found, except for mutant 40.1-10, which underwent a 12 nucleotide deletion leading to a 4 amino acid deletion. The observed genetic changes were all located within the amino acid stretches previously assigned either to the D site (chymotrypsin 13 kDa fragment; position Asn-82 to or to the spatially related A and B sites (collagenase 26 kDa fragment; position Ser-506 to Pro-651) (Delmas et al., 1990; Godet et al., 1994) . No mutation could be determined unambiguously for mutant 40.1-4. For mutant 12.18-1, it was concluded that region(s) located outside the A/B domain were mutated.
Setting up the animal model
In a preliminary experiment, suckling piglets, randomly assigned into two litters, were oronasally infected at 4 days of age with 1 x 108 p.f.u, of Purdue-115 strain virus each. The mortality rate was 75 % (6/8) in one litter and 10% (1/10) in the other. It was concluded that the influence of the mother may occasionally be too important to allow a reliable evaluation of the pathogenicity of mutants derived from this strain. It was therefore decided to use artificially reared piglets, an experimental system which proved to be satisfactory in earlier experiments (La Bonnardi~re & Laude, 1981) . In the present study, however, the piglets were not hysterectomy-derived but weaned at 3 days. The virulence of the different viruses was evaluated according to the following criteria: (i) severity of the enteritis syndrome (onset of diarrhoea, number of ill animals); (ii) daily weight gain; (iii) mortality (rate, day of death). Table 2 and Fig. 1 summarize the results obtained in seven distinct groups of animals infected with Purdue-115 at infectious doses ranging from 1 x 104 to 1 × 10 s p.f.u, per animal. All 27 infected animals developed signs of anorexia, vomiting and severe diarrhoea between 3 and 3.5 days p.i. and died within 4 to 8 days p.i. The mean daily weight gain from day 1 p.i. was between -46 g and -8 g, excepted in one group ( + 5 g), whereas that of the uninfected piglets ranged from + 120 to + 173 g ( Table 2 ). The growth curves show that the weight gain at death of the infected piglets was nil or negative, whereas that of the control piglets increased regularly from 4 to 14 days after birth (Fig. 1) . No clear relationship between the dose of inoculation and the mortality and morbidity rates was evident, although the piglets infected with ~> 107 p.f.u, died approximately 2 days before those infected with ~< l0 s p.f.u. Two other TGEV strains were also tested for comparison (Table 2 and Fig. 1 ). Piglets infected with the fully virulent strain Gep II showed a significant loss of weight from 1 day p.i. Gep II k -6/6 -87± 19 6/6 * Animals from groups designated by the same letter in Table 2 and 3 were infected or mockinfected at the same time. A bold letter indicates complementary data presented in Fig. 1 .
t From day 1 p.i. onwards.
and died within 4 days p.i. The attenuated strain Nouzilly induced a mild diarrhoea, which led to a slight change in the growth curve, and all the infected piglets recovered. From these data it was concluded that the model system chosen was reliable enough to differentiate TGEV viruses in term of pathogenicity.
Pathogenicity of the Purdue-l l5 mutants
Twelve independent mutants were analysed under the conditions described above. The resulting data are summarized in Table 3 and Figs 2 and 3. The phenotypes of the site A and B mutants tested could not be distinguished from that of the parental virus with respect to onset and severity of diarrhoea and mortality rate (100 % death within 4.5 to 6"5 days p.i.). The mean daily weight gain ranged from -67 g to + 8 g for an infectious dose of 107 to 10 s p.f.u. The growth curves were very similar in shape to those using the parental virus at the same doses (Fig. 2) . The only exception was infection with the small plaque mutant 12.18, for which the loss of weight of the piglets was reduced and 1/3 of the animals survived.
In contrast, a high proportion (5/7) of the 40.1 mutants appeared to be substantially attenuated. Indeed, inoculation with ~< 107 p.f.u, of mutants 5 to 8 and 10 resulted in a mortality of 1/32 for all of the groups. The mean daily weight gain was between + 122 g and + 190 Fig. 1 . Daily weight gain and survival of newborn piglets mock-infected or infected with the Purdue-115 strain (from which the epitope mutants studied were derived), the field strain Gep II and the vaccine strain Nouzilly. The Purdue strain was inoculated at four different doses, expressed in p.f.u. The number of animals per group is indicated in brackets. The mean daily weight gain (± SEM) was calculated using the weight at the day prior to infection as a reference. The animals were weighed every day. The day of death is indicated by (+).
g, and the growth increased regularly, like that in control groups when the infectious dose was 105 p.f.u. (Fig. 3) . When inoculated at 108 p.f.u., these mutants induced significantly less morbidity and mortality than the parental strain even inoculated at 104 p.f.u. Also, in contrast to the situation observed with the parental strain, an effect of the dose of inoculation was noticeable. Two additional 40.1 mutants (4 and 9) were not inoculated at titres ~< 1077. However, the shape of the growth curve as well as the mortality rate (1/3 animals surviving at 10 days p.i. against 0/3 surviving at 6 days with the parental virus at a dose 100-fold lower) indicate that these two mutants are at least moderately attenuated. * Animals from groups designated by the same letter in Table 2 and 3 were infected or mock-infected at the same time. A bold letter indicates complementary data presented in Fig. 2 (site A and B mutants) or in Fig. 3 
Discussion
In the present study, we have investigated the effect of site-specific alterations of the spike protein S on the enteropathogenicity of TGEV. Twelve independent, neutralization-resistant mutants selected against MAbs defining the major antigenic sites A, B and D (Delmas et al., 1986 (Delmas et al., , 1990 were analysed for their pathogenicity in the newborn piglet. Site C mutants were not included as this site maps on a sequence of around 10 amino acids that exhibits natural variation among the wild TGEV strains. The animal model used consisted of artificially reared piglets weaned at 3 days and infected at 5 days of age. This model proved to be more convenient than suckling piglets in differentiating virus strains with respect to virulence, both in terms of morbidity and mortality. In these conditions, oronasal inoculation of 104 p.f.u, of the cell-adapted, high passage Purdue-115 strain induced an acute enteritis syndrome and killed 100 % of animals within ~< 8 days. The clinical outcome was found to be similar to that observed in earlier experiments in which hysterectomy-derived, colostrumdeprived piglets were used (La Bonnardi~re & Laude, 1981 , 1983 , except that the appearance of the diarrhoea and death were delayed by 2 days on average. In an earlier study (Frederick et al., 1976) , the Purdue-ll5 strain was found to induce a mild diarrhoea and no mortality, in striking contrast with the above results. There is no clear explanation for such a discrepancy.
Propagation of the virus in a different cell system (ST cell line instead of primary pig kidney cells) and overnight starving before infection are factors which might possibly account, at least in part, for the observed virulence of Purdue-115 virus in the neonate. As expected, however, this strain appeared to be attenuated compared to a fully virulent strain, like the Gep II strain used here (Fig. 1) .
The present study involved 27 and 76 animals infected with the parental virus Purdue-115 and with mutant viruses, respectively, and 20 mock-infected animals. The main finding emerging from the data is that the majority (5/7) of the mutants selected toward site D (MAb 40.1) were markedly less pathogenic compared to the wildtype virus. Relevant changes in the amino acid sequence were identified for six of these mutants by partial sequencing of genomic RNA. All the predicted modifications were found to be clustered within a short amino acid stretch at positions 145 to 155 from the mature S protein N terminus (Table 1) . Three distinct point mutations were correlated with an attenuated phenotype: Pro-145 to Leu (mutants 40.1-6 and -7), Cys-147 to Arg (40.1-8) and Cys-155 to Phe (40.1-5). It is notable that each replacement affected a proline or a cysteine, two amino acids which play a role in terms of secondary structure. One variant (40.1-10) was predicted to encode an S polypeptide truncated by four residues at position 146 to 149. Examination of the parental nucleotide sequence revealed the presence of a CTA triplet which is repeated 9 bases downstream ( Table 1 ), suggesting that the deletion event was due to a brief polymerase sliding. The animals which received one of the above five variants (40.1-5 to -8 and -10) at doses 3 to 4 log1, higher than the lethal dose of parental virus developed a mild diarrhoea and all survived. Apparently, the 4 amino acid deletion did not result in an increased level of attenuation compared to that of viruses having a single amino acid change in that region. Two additional site D mutants tested, 40.1-9 (Ser-149-Pro) and 40.1-4 (mutation unidentified), were at least moderately attenuated. Together these data thus support the notion that a single coding change in this region of the 1431 residuelong S polypeptide chain (Rasschaert & Laude, 1987) may substantially affect the enteropathogenicity of TGEV. Actually, the level of attenuation reached that of a strain used for vaccination of the pregnant sow (see Fig. 1 ).
It should be pointed out that, apart from the site A 12.18 mutant which had a small plaque phenotype, all the mutants studied here grew in cell culture at the same rate as the parental virus and exhibited a normal plaque phenotype (Delmas et al., 1986; data not shown) . This indicates that neither virus-to-cell binding nor essential steps in the replication of the attenuated 40.1 mutants were impaired in vitro. While the possibility cannot be ruled out that additional, non-silent genetic changes may reside outside the S gene, this seems to be highly unlikely since (i) all the mutants (except 12.18) were naturally occurring variants which were isolated with a frequency of 10 -5 to 10 65/wild-type p.f.u. (Delmas et al., 1986) , a value consistent with the single mutation rate of singlestranded RNA viruses (for review see Smith & Inglis, 1987) ; (ii) most site D mutants (5/7) were strongly attenuated and most site A/B mutants (3/4) exhibited a virulence phenotype like that of the parental virus, although both groups of mutants were generated following the same approach; (iii) two independent variants (40.1-6 and -7) with the same point mutation behaved similarly in infected animals.
Altogether these data provide the first demonstration that determinants imparting the enteropathogenicity of TGEV are associated with the S protein. Similar findings have been reported for MHV, as it was shown that mutations or deletions located mainly in the S1 (Nterminal half) subunit notably affected the neurovirulence of this virus (Fazakerley et al., 1992; Wang et al., 1992) . In the case of TGEV, the alterations assumed to confer the attenuated phenotype mapped in the Nterminal region of the S polypeptide. This is of interest considering that this region is absent in the S protein encoded by PRCV, the respiratory variant of TGEV (for review see Laude et al., 1993) . Indeed, the PRCV S protein is truncated by 224 (European isolates) to 227 (American isolates) amino acids near the N terminus Wesley et al., 1991) . The present findings lend strong support to the view that the S protein truncation observed in PRCV contributes to the nearly complete lack of replication of this virus in the digestive tract (Cox et al., 1990) . This, however, does not preclude the possibility that additional genetic lesion(s) account for the loss of pathogenicity of PRCV. In this respect, ORF 3-1 has been shown to be a pseudogene in the PRCV genome and the attenuated TGEV strains Miller SP and Nouzilly (Wesley et al., 1990; Britton et al., 1993) both have a small plaque phenotype and a truncation within the homologous ORF 3a, putatively encoding a non-structural protein (for review see Laude et al., 1993) . In contrast, all of the site D, attenuated mutants synthesized an mRNA 3 species of the standard size according to Northern blot analysis (data not shown).
The fact that mild diarrhoea developed in animals infected with the highest doses of the attenuated 40.1 mutants suggests that their multiplication in the intestine is severely impaired but not abolished. Alternatively, the residual enterovirulence might reflect the emergence of genotypical or phenotypical (compensatory amino acid change) revertants. Genotypical reversion, however, appears to be unlikely since an ELISA-based analysis of faecal antigen (Bernard et al., 1986) performed for three of the mutants revealed that the excreted material was not recognized by the selector MAb (data not shown). Further studies including virus isolation and histopathological analysis should allow us to determine whether the attenuation reflects a qualitative (i.e. infection of a specific portion of the small intestine) or quantitative restriction of virus multiplication. Finally, it would be of utmost interest to determine whether these mutants retain the capacity of the parental, cell-adapted Purdue-115 virus to replicate in the respiratory tract (La Bonnardi6re & Laude, 1983; Laude et aI., 1984; VanCott et al., 1993) .
The function associated with the region of the S polypeptide chain where amino acid changes (40.1 mutants) or deletions (40.1-10 mutant, PRCV strains) are observed remains elusive. Assuming that the attenuation is actually due to a lowered ability of the virus to initiate a productive infection in the small intestine enterocytes, at least two lines of hypotheses may be invoked. Different receptor-binding sites in TGEV S protein could be recognized by the enteric and respiratory tissues, as speculated by other authors (Sanchez et al., 1992) . We have reported that both TGEV and PRCV use APN as a receptor for gaining entry into cells (Delmas et aI., 1992 (Delmas et aI., , 1993 and that the receptor binding site involves a region of the S protein (containing the A and B neutralization sites) which is common to both viruses (Godet et al., 1994) . The possibility still remains, however, that the N-terminal domain interacts with a cell surface molecule expressed by the enterocytes but not by the respiratory epithelium. Another conceivable mechanism would be that the N-terminal domain is required for a proper folding of the S molecule within a compartment of the digestive tract, where physicochemical factors might differentially affect the conformation of the wild-type protein and that of the mutated or truncated one.
